Cite
HARVARD Citation
Linder, K. et al. (2015). Complete remission after single agent blinatumomab in a patient with pre-B acute lymphoid leukemia relapsed and refractory to three prior regimens: hyperCVAD, high dose cytarabine mitoxantrone and CLAG. Experimental hematology & oncology. 5 (1), pp. 1-4. [Online].